Nipro Vialex – 26th January 2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Nasal & Pulmonary Drug Development
Novo Nordisk 20 March 2024, 11:21
Carterra – 24th March 2025

Pathway for Marketing Authorisation Approval of Medical Device in US

The process of developing a revolutionary medical device from the proof-of-concept stage to the marketing stage is expensive and complicated. The creation of a new product is a costly and time-consuming endeavour. Demonstrating the safety and efficacy of the technology is just as crucial as the innovation itself. Deeksha K S, et all at JSS College of Pharmacy, discusses why these requirements can assist you to update your development operations and create a product that fulfils the regulatory standards of a safe and effective product for its intended application.

Scott Pharma – 25.03.2025
SMI – 24/03/2025
Chemspec Europe – 27.02.2025
PHARMAP: Mon 14 October 2024, 10.36
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
L.B. Bohle – 08.04.2025